Ghadirian A M, Nair N P, Schwartz G
Department of Psychiatry, McGill University, Montreal, Quebec, Canada.
Biol Psychiatry. 1989 Jun;26(2):139-44. doi: 10.1016/0006-3223(89)90017-6.
Patients treated with a combination of lithium (Li) and neuroleptics are reported to be at greater risk for toxicity. Previous findings suggested that treatment with a combination of Li and neuroleptics would increase the lithium ratio (LR) and intraerythrocyte Li levels. We studied 67 bipolar patients who were treated with Li alone (20 patients) or Li combined with haloperidol (17 patients), or Li combined with chlorpromazine (30 patients). Results revealed that the neuroleptic groups showed significantly lower LR and intracellular Li concentration as compared with those on Li alone. There was no significant difference in Li dosage among these three groups. No difference was found among these three groups with respect to mean blood pressure and weight. The number of hypertensive patients in the Li only group was twice as high as that in either of the two other groups, and the LR of the former was significantly higher than those of the latter groups.
据报道,接受锂盐(Li)和抗精神病药物联合治疗的患者出现毒性的风险更高。先前的研究结果表明,锂盐与抗精神病药物联合治疗会增加锂比值(LR)和红细胞内锂水平。我们研究了67例双相情感障碍患者,其中20例单独接受锂盐治疗,17例接受锂盐联合氟哌啶醇治疗,30例接受锂盐联合氯丙嗪治疗。结果显示,与单独使用锂盐的患者相比,联合使用抗精神病药物的组LR和细胞内锂浓度显著降低。这三组的锂盐剂量没有显著差异。这三组在平均血压和体重方面没有差异。仅使用锂盐组的高血压患者数量是其他两组中任何一组的两倍,且该组的LR显著高于其他两组。